News
🇺🇸 FDALatest pharmaceutical news, drug approvals, and FDA regulatory updates
Showing 1–12 of 818 articles
Quick answer
NovaPharmaNews United States & Americas news feed tracks 818 published stories — FDA regulatory actions, clinical trial readouts, M&A, and commercial milestones for pharma BD, investors, and market access teams. Browse by topic, explore linked company and drug profiles, or switch to analysis for deeper commentary.
FDA approves Merck oral PCSK9 drug
Lexitas Ocusun dose first patient in cataract pilot
FDA Approves New Breast Cancer Drug Revtorpyk
FDA Activity Round Up July 2026
FDA Finalizes Guidance on Clinical Trial Design
Summit Therapeutics Refocuses on Oncology Drug
Study China outpaces the US in cancer approvals
Drug Repurposing Stakeholders Say FDA Should Act
Commissioner National Priority Voucher CNPV Pilot
Compounded GLP-1s Why doctors worry and FDA acts
Enlicitide Wins FDA Nod as First Oral PCSK9 Inhibitor
Adial Pharmaceuticals Azora merger and AT177
Frequently asked questions
What does the regional news feed cover?
Breaking pharmaceutical news for the selected edition — regulatory actions, clinical readouts, corporate announcements, partnerships, and market-moving signals. Each story links to company profiles, drug INN pages, trials, and events where entities are tagged.
How is news different from analysis on NovaPharmaNews?
News covers timely regulatory and commercial developments. Analysis & Commentary provides in-depth opinion, market context, and expert interpretation. Use the content-type chips above to switch between latest news and analysis hubs.
How often is this feed updated?
New articles publish continuously as FDA, EMA, PMDA, NMPA, and other agency signals break. Subscribe to the weekly digest in the sidebar for a curated Monday roundup.